SHELBY PARRISH: Open Payments
NPI 1295227064 · BERKELEY HEIGHTS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 45 payments from 14 companies in 2025. Trend: 2023 $403 · 2024 $468 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $146 |
| GENZYME CORPORATION | 4 | $65 |
| Novartis Pharmaceuticals Corporation | 3 | $54 |
| Galderma Laboratories, L.P. | 3 | $52 |
| Botanix SB Inc | 3 | $52 |
| Amgen Inc. | 3 | $51 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $37 |
| Arcutis Biotherapeutics, Inc. | 2 | $35 |
| Incyte Corporation | 1 | $18 |
Products named: SKYRIZI, DUPIXENT, COSENTYX, NEMLUVIO, SOFDRA, OTEZLA, Zoryve, ILUMYA.
Industry payments across NJ — which companies pay providers there.
